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Drug resistant infections are an increasing problem world-wide, with an annual 
estimate of 300,000 infections a year, 10,000 deaths, and 1.7 billion dollars in costs in the 
US alone.  Current treatment modalities to combat infections of this type rely on 
antibiotics. Unfortunately, the use of antibiotics accelerates the development of 
resistance. Severe drug resistant infections such as methicillin-resistant Staphylococcus 
aureus (MRSA) are often managed with “last resort treatments”, which have side effects 
similar to chemotherapy, including, but not limited to, loss of appetite for months at a 
time, increased hospital stays, and extreme fatigue. MRSA produces a host of toxins that 
are responsible for its virulence, causing inflammation, skin lesions and, in extreme 
cases, septic shock and even death. One potential alternative strategy for treating drug 
resistant bacterial infections would be to inhibit the production of these toxins, thereby 
making the bacteria less harmful to the host; a so called “anti-virulence” approach. A 
major advantage of anti-virulence therapeutics would be the ability to reduce the damage 
caused by bacterial infections without selecting for the development of resistance.  
The long-term goal of our research is to develop new anti-virulence strategies 
against MRSA.  With this dissertation, we undertook three projects towards this goal.  
With Project 1, we developed analytical methodologies to better understand and track 
virulence in MRSA by measuring molecules that are regulated by and regulate the quorum 
sensing system. With Project 2, we sought to identify new secondary metabolites 
 
 
produced by MRSA, with a particular focus on those regulated by the quorum sensing 
system.  Lastly, with Project 3, we employed new informatic approaches to identify 
antimicrobial compounds from the plant Rumex crispus. This third project also included a 
significant training component and was carried out collaboratively with an undergraduate 
student. A central goal of this dissertation in addition to benchwork science was to recruit 
and retain a diverse body of students in chemistry. This goal was carried out through 
effective mentorship and training, as evidenced by the outcomes of Project 3.
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Antimicrobials and Medicine  
It is imperative to understand the role of antibitotics in improving human health.  
Antibitocits are arguably one of the greatest success stories in the history of medicine. 
The discovery of antimicrobials started a medical revolution known as the antibiotic era.   
This chapter provides a brief history of the discovery of some antimicrobials and how 
many lives were saved since their first serendipitous discovery.  
The antibiotic era is usually associated with Alexander Fleming and Paul Ehrlich 
[1]. Ehrlich's idea of a "magic bullet" that could selectively target only disease-causing 
microbes and not the host was based on an observation using synthetic dyes like aniline. 
It was further observed that these dyes could only stain specific types of microbes. Based 
on these observations, Ehrlich claimed that these chemical compounds could be 
synthesized and would be able to target the pathogenic microbe [1] exclusively. Ehrlich 
first described this concept in 1900. Erhlich clearly stated that these chemicals harmed 
the pathogens and not the host [1, 2]. One of the first "magic bullets" that were successful 
in treating syphilis was arsphenamine. Through Ehrlic's concept of the magic bullet, the 
first naturally occurring antimicrobial was discovered [2]. The golden age of the 




that contaminated his petri dishes while he was conductinginfluenza studies [1-3]. 
Penicillin was a hallmark for treating infections and diseases associated with 
Staphylococcus aureus. This was great news for the medical field until they noticed that 
the illnesses were becoming harder to treat because of the resistance it had to begin to 
develop.  
Developing Resistance to Antimicrobials   
Staphylococcus aureus is a commensal bacterium that colonizes the normal skin 
and nasal cavity in approximately a third of the human population [4]. In addition to S. 
aureus commensal characteristics, it can become a pathogen to a human or animal host. 
This activity meants that it is characterized as an opportunistic pathogen. S. aureus causes 
a wide range of infections, some of the most severe conditions being septicemia and toxic 
shock syndrome. These infections and associated diseases could be life-threatening if left 
untreated [4], and S. aureus is a leading cause of human bacterial infections worldwide 
[5]. The Centers for Disease Control had classified S. aureus as one of the high priority 
pathogens, with infection rates in the hundreds of thousands and the deaths in the tens of 
thousands [6].  
  S. aureus is a high priority pathogen listed by the CDC because it can develop 
resistance rapidly to newly developed antibiotics. The go to antimicrobial for S. aureus in 
its multi-drug resistant form is vancomycin, and there are strains resistant to this last 
resort antimicrobial, making it challenging to treat [6].  
S. aureus' unique ability to develop resistance to many antibiotics classes has 




methicillin-resistant Staphylococcus aureus or MRSA [7]. The current treatment modality 
for this highly antibiotic-resistant pathogen consists of a cocktail of drugs with similar 
effects to chemotherapy. We have heard patients describe their symptoms concurred with 
research reviews [8], loss of appetite, extreme fatigue, inability to work, excessive weight 
loss, and many others. MRSA has become more prevalent in recent years as a 
community-acquired (C.A.) infection; most infections were hospital-acquired (H.A.). 
Over the last decades, this CA-MRSA has been the most prominent cause of drug-
resistant S. aureus infections [9]. 
Antibiotics that were once active against CA-MRSA are no longer useful, 
resulting in a need for more antimicrobial drug discovery efforts [8]. Antibiotics kill 
bacteria through various modes of action, including damage to the cell wall and inhibition 
of DNA synthesis [8]. The selective pressure applied to bacteria exposed to antibiotics 
results in the evolution of resistance mechanisms, making many antibiotics ineffective 
[10]. Increased resistance is, in part, due to the overuse of antibiotics [7, 11].  
Need for new ways to treat infections 
With this dissertation, we sought to develop methods that would improve our 
understanding of molecules secreted by MRSA [12, 13] that allow it to thrive in hostile 
environments. This ability to succeed is often referred to as virulence [14]. It is 
imperative to seek alternative treatment modalities in conjunction with continuing efforts 
in antibiotic drug discovery. The first project in this study aimed to develop an analytical 
methodology to detect known MRSA metabolites, enabling tracking of MRSA growth 




tools to answer these biological questions. Mass spectrometry is one of the most effective 
technologies for targeted and untargeted analysis, outlined in detail by previous peer-
reviewed literature [6, 15-17]. Throughout this dissertation, we detail how mass 
spectrometric methods were employed to answer questions from a chemical and 
biological perspective.  Using this tool, we made significant progress in identifying 
unknown virulence compounds or degraded products of virulence products that may have 
a biological function.  Finally, we putatively identified molecules that inhibit bacterial 
growth from a botanical source, the plant Rumex crispus.  
Commitment to Mentorship as a way to Increase Diversity  
Throughout this dissertation, a significant effort was focused on the recruitment 
and mentorship of people from underrepresented communities. This effort was made to 
aid in diversifying science. While progress has been made in the science, technology, 
engineering, and mathematics (STEM) field is still sorely lacking diversity. Encountering 
black or brown people with a Ph.D. (or in pursuant of a Ph.D.) is surprising. But to see a 
black person who is also a part of the LGBTQIA+ community can be disturbing and 
challenging for students (undergraduates, post-baccalaureate, and advanced degree 
seekers) who are attempting to get a degree in the same or similar field. Similar to the 
concept of a syndemic in the epidemiology literature [18], the social sciences have urged 
us to consider how social context intersects with other variables by offering the 
framework of intersectionality for our consideration [19]. In short, intersectionality is 









Figure 1.1. Concept of intersectionality visualized. The overlapping of each of the 




With this knowledge, the mentorship of those not typically seen in the field is of 
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Staphylococcus aureus is a Gram-positive bacterium that colonizes the mucosal 
membranes and epithelial surfaces of more than 30% of the healthy adult population [20, 
21]. S. aureus causes infections in both healthy and immunocompromised individuals 
[14, 22], and methicillin-resistant S. aureus (MRSA) is one of the most problematic 
multi-drug resistant pathogens, responsible for more than 10,000 hospital-acquired 




in hospital settings, over the past two decades, there has been an increase in community 
acquired MRSA infections [5, 22]. The MRSA strains most commonly associated with 
community acquired infections are characterized by their hyper-virulence, which results 
from their production of high levels of toxins that cause inflammation and tissue damage 
[9].  Thus, it has been suggested that a promising strategy for combating MRSA 
infections would be targeting toxin production, a so-called “anti-virulence” approach.  
Toxin production in MRSA is controlled by two-component regulatory systems, 
most importantly the accessory gene regulatory (agr) system [23, 24].  Activation of this 
system occurs in a cell-density dependent fashion when an autoinducing peptide (AIP) 
secreted by the bacteria binds to the extracellular receptor AgrC, a membrane-bound 
histidine kinase.  Binding of AIP to AgrC induces changes in gene expression that 
ultimately lead to the production of multiple virulence factors, including the phenol 
soluble modulins (PSMs).  
Previous investigations have sought to track virulence in MRSA by measuring 
quorum sensing regulated metabolites.  For example, our group and others have detected 
the AIPs directly from bacterial culture media [25-29].  Others have reported the 
detection of outputs of the quorum sensing system such as phenol soluble modulins 
(PSMs) [30-33] including delta toxins [33-35]. The limitation of measuring these 
metabolites to monitor virulence is that it is difficult to disentangle anti-virulence activity 
from anti-microbial activity; inhibition or delay in bacterial growth will have the same 
effect (decrease in metabolite production) as inhibition of quorum sensing.  Prior to the 




sensing and tracking bacterial density with OD600 readings [26, 36].  With the current 
study, we sought to develop an alternative strategy, the application of a mass 
spectrometric method that could simultaneously monitor multiple classes of secondary 
metabolites produced by MRSA, including metabolites controlled by the agr system (as 
an indicator of virulence) and those that are not (as an indicator of growth).   
In conducting this study, we predicted that the aureusimines might be useful metabolites 
to employ for the purpose of monitoring S. aureus growth.  Production of aureusimines 
by S. aureus has been independently discovered by the Fischbach and Magarvey research 
groups [37, 38]. Aureusimine biosynthesis is dependent on the ausAB operon, also 
referred to as pznAB operon, which encodes a nonribosmal peptide synthetase (ausA) and 
4′-phosphopantetheinyltransferase (ausB). An early report [38] had suggested 
aureusimines to be major virulence regulators in S. aureus, but a more recent study 
showed that these regulatory effects were due to a secondary mutation in the SaeRS two-
component system[39]. Therefore, the biological role of aureusimines has yet to be 
determined.  With this study, we endeavored to test the utility of tracking aureusimine 
production as a way to monitor MRSA growth. 
 Materials and Methods  
 MRSA culture for monitoring metabolite production over time 
Methicillin-resistant Staphylococcus aureus (LAC USA300) was used for these 
experiments [25]. A 24 hr culture was grown in Mueller Hinton Broth (MHB) at 37°C 
with shaking at 200 rpm using a New Brunswick Scientific shaker/incubator series I-26.  




mL of MHB at a dilution of 3.7 × 108 CFU (colony forming units). Every 2 hr, a 500 µL 
aliquot was removed from each flask and the OD600 was measured.  Also, at each time 
point a second aliquot was removed, filtered with a 0.22 µm centrifugal filter with a 
polyvinylidene difluoride (PVDF) membrane, and the filtrate was retained for analysis 
with ultraperformance liquid chromatography-mass spectrometry (UPLC-MS).  
MRSA culture for growth and quorum sensing inhibition 
A slight modification of a previously described method was used to evaluate the 
influence of inhibitors on MRSA metabolite production [40].  Briefly, MRSA (LAC 
USA300) was cultured at 37 °C in tryptic soy broth (TSB) for 24 hr with shaking at 200 
rpm in a New Brunswick Scientific shaker/incubator series I-26.  This culture broth was 
diluted 1:100 in TSB and cultured with shaking at 200 rpm at 37 °C for 2 hr, at which 
point the OD600 was measured to be in the range of 0.08-0.1.  A 96-well tissue culture 
treated flat bottom plate (Corning Incorporated) was inoculated with 245 µL of this 
diluted bacterial inoculum and 5 µL of inhibitor or control in each well.  The inhibitors 
included ambuic acid (Adipogen life Sciences) and chloramphenicol (Sigma Aldrich) at 
assay concentrations of 0.77 µM to 100.00 µM and 2.34 µM to 300.00 µM, respectively. 
Stock solutions of ambuic acid and chloramphenicol were prepared in DMSO and assay 
content of DMSO was 2% in all wells.  Assays were performed in triplicate for each 
treatment and control.  The vehicle control consisted of 2% DMSO. The plate was 
incubated at 37 °C and shaken at 1000 rpm in a Stuart Microtitre Shaker Incubator 
(SI505).   OD600 was measured at 1 hr intervals using a Synergy H1 Plate Reader and the 




incubation time, the culture broth containing bacteria was transferred to a clear sterile 96-
well, 0.22 µm hydrophilic plate with low protein binding durapore membrane 
(MultiScreen®) and filtered under vacuum.  The spent media were then analyzed by 
UPLC-MS.   
MRSA culture for experiments with deletion mutants 
Three strains of MRSA were used in these experiments, a clinical isolate referred to as 
MRSA LAC USA300 (AH1263) [41] and a genetic deletion mutant engineered to knock 
out aureusimine production (AH2137), and a genetic deletion mutant engineered to knock 
out the agr quorum sensing system (AH1292) [35].  Triplicate samples of a diluted 24 hr 
inoculum (prepared as described in MRSA culture for growth and quorum sensing) of 
each strain (30 mL total volume) were cultured in MHB in 50 mL falcon tubes for 24 hr 
with shaking at 200 rpm at 37 °C.  At the 24 hr time point, each culture was filtered with 
a centrifugal filter (PVDF) and the spent medium was analyzed by UPLC-MS.  
To construct the AH2137 ausA deletion plasmid, homology arms (~1100 bp) upstream 
and downstream of ausA were amplified with primer pairs (IDT) CLM508/CLM512 and 
CLM510/CLM511 (Table 2.1). The PCR products were column purified with the 
QIAquick PCR purification kit (Qiagen) and fused in a second PCR with primers 
CLM508 and CLM511. The PCR product was gel purified with the QIAquick gel 
extraction kit (Qiagen), digested with SacI and SalI (New England BioLabs Inc), and 
ligated into plasmid pJB38 [42] digested with the same restriction enzymes to generate 
plasmid pCM44. The plasmid was electroporated [43] into strain RN4220 [44] and clones 




µg/ml) at 30 °C. The plasmid was recovered with the QIAprep Spin Miniprep Kit 
(Qiagen) from overnight cultures grown at 30 °C in TSB containing Cm (10 µg/ml) and 
sequenced with primers SEQ, REVCOMPSEQ and SEQ62D. The plasmid was then 
electroporated into USA300 strain LAC, clones carrying pCM44 were selected on TSA 
plates containing Cm (10 µg/ml) and individual colonies were subsequently streaked on 
TSA plates containing Cm (10 µg/ml) and incubated at 42°C to select for integration into 
the chromosome. Single colonies were grown in TSB at 30°C with shaking and diluted 
1:500 in fresh media for four successive days before diluting to 10−6 and plating on TSA 
containing 200 ng/ anhydrotetracycline to select for loss of the plasmid. Colonies were 
screened for resistance to Cm, and CmS colonies were screened by PCR for deletion 
of ausA. 
 
Table 2.1. Primer list 
Primer 
Name 














CLM511 GTTGTTGTCGACCACTGACTAACATTAACGTGAG SalI 







SEQ62D CTCACGTTAATGTTAGTCAGTG  
a. Restriction sites are underlined 




An Acquity UPLC system (Waters, Corporation, Milford, MA) coupled to an 
LTQ-Orbitrap XL hybrid mass spectrometer (Thermo Fisher Scientific, Waltham, MA) 
was used for UPLC-MS analyses. For the samples collected in the 24 hr growth analysis 
(Section 2.1) a 3 µL injection of each sample was eluted from the column (Acquity 
UPLC BEH C18 1.7 um, 2.1 x 50 mm, Waters Corporation) at a flow rate of 0.3 mL/min 
with solvent A consisting of water (Optima LC-MS grade) with 0.1% formic acid added 
and solvent B consisting of methanol (Optima LC-MS grade). The gradient was initiated 
with an isocratic composition of 60:40 (A:B) for 0.5 min, increasing linearly from 0.5 
min to 7.50 min  to 30:70 (A:B) followed by an isocratic hold for 0.5 min. From 8.0-8.5 
min the gradient increased linearly to 0:100 with a 0.5 min isocratic hold. The gradient 
returned to initial starting conditions from 9.0-9.5 min and was held for 0.5 min. The 
mass spectrometer was operated in positive ion mode for the scan range of 150-1500 with 
the following settings: capillary voltage of 5 V, capillary temperature of 300 °C, tube lens 
offset of 35 V, spray voltage of 3.80 kV, sheath gas flow of 35, and auxiliary gas of 20. 
The same method was employed for samples from the growth inhibition studies (Section 




(Acquity UPLC BEH SHIELD RP C18 1.7 um, 2.1 x 50 mm, Waters corporation) was 
used. 
To identify selected MRSA metabolites, MS-MS analysis was conducted using 
collision-induced dissociation (CID) with a collision energy of 35.0.  Fragmentation 
patterns, retention times, and accurate masses were compared between putative 
metabolite signals in the MRSA culture medium and data for standards for AIP-I 
(Anaspec), δ-toxin (Anaspec) and aureusimine B (Cayman chemicals).  Data dependent 
acquisition was employed with an inclusion list for the masses of 961.3798 (AIP-I), 
229.1332 (aureusimine B) and 752.4135 (δ-toxin).  A calibration curve was also collected 
for the AIP-I standard to establish the linear range of instrument response, using a 
concentration range of 1.0 × 10-4  to 1.0 × 101 µg × mL-1.   
All mass spectrometric data have been made publicly available through MassIVE 
(MassIVE ID: MSV000085457, doi: 10.25345/C5WT5R, 
https://massive.ucsd.edu/ProteoSAFe/dataset.jsp?accession=MSV000085457).  
 Untargeted metabolomics procedures 
`Untargeted metabolomics data analysis was conducted on the mass spectrometric 
data for samples generated in the growth inhibition studies (MRSA culture for growth and 
quorum sensing inhibition).  Mass spectrometric data were analyzed, aligned and filtered 
with MZmine 2.2 software (http://mzmine.sourceforge.net/) [45]. The parameters can be 
found in Table2.2. Briefly, peak detection in MZmine was obtained above a baseline of 
1.2 × 106 and a chromatogram was constructed for each of the m/z values that spanned 




level (absolute value) at 1.2 × 106, minimum peak duration 0.5 min, tolerance for m/z 
variation 0.001 and tolerance for m/z intensity variation 10%. The join aligner algorithm 
was used to create a compiled peak table by setting the balance between m/z and retention 
time at 10.0 each, m/z tolerance at 0.05, and retention time tolerance as 2 min. The 
spectral data matrix was imported to Excel (Microsoft, Redmond, WA, USA) and the 
OD600 data were included to form a final data matrix.  Using optical density (OD600) as 
the dependent variable, we conducted multivariate statistical analysis to construct 4-
component partial least squared scores and loadings plots. From the univariate model, 
selectivity ratio analysis was conducted using Sirius 10.0 (Pattern Recognition Systems 
AS, Bergen, Norway).  This approach was used to identify which features of the dataset 
(detectable ions/independent variables) were correlated with growth. 
 
Table 2.2.  Parameters used for UPLC-MS analysis.  
Noise level (absolute value) 1.2 × 106 
Minimum peak duration 0.5 min 
Tolerance of m/z variation 0.001 
Tolerance for m/z intensity variation 20% 
Balance between retention time and m/z 10 
m/z tolerance 0.05 





Results and Discussion  
Untargeted metabolomics of a growth curve to detect MRSA metabolites 
To inform the selection of analytes for targeted mass spectrometric analysis, we 
first conducted untargeted mass spectrometry metabolomics experiments.  Critical in 
these experiments was the application of a data analysis tool, the selectivity ratio, which 
enables complex mass spectrometric datasets to be simplified by identifying features 
associated with a given dependent variable [6, 46, 47].  Using untargeted metabolomics 
with selectivity ratio analysis, we sought to identify specific MRSA metabolites that 
could be detected as increasing in abundance with increasing OD600.   
Untargeted metabolomics analysis of MRSA cultures is complicated by high 
levels of background introduced by the rich culture medium.  This high level of 
background makes it difficult to distinguish the signals for MRSA metabolites of interest 
from spurious signals resulting from the culture medium.  To resolve this issue, we 
analyzed a time-dependent series of MRSA cultures using UPLC-MS and conducted 
untargeted metabolomics analysis of the combined dataset.  We then employed selectivity 
ratio analysis [48] to determine which features in the metabolomics dataset were 
correlated with bacterial growth (as measured by OD600) (Figure 2.1).   The selectivity 
ratio serves as a ranking tool, indicating which features are more likely to be associated 
with the dependent variable (in this case growth).  For a given study, the investigator may 
select a selectivity ration cut-off value for which features to include in the dataset.  This 
cut-off value can be adjusted up or down depending on the research question being asked.  




all of the known MRSA metabolites had selectivity ratios greater than or equal to this 
value. 
In Figure 2.1, features (m/z retention time pairs) that correlate with growth 
(OD600) are indicated by positive selectivity ratios. Of the 2090 features detected above a 
signal intensity of 1.2 × 106 with untargeted UPLC-MS metabolomics across the twelve 
timepoints of the growth experiment, only 5% had selectivity ratios above 0.36, more 
than half of these (49 ions) were putatively identified as isotopes, multiply charged ions, 
or adducts associated with seven known MRSA metabolites based on accurate mass 
values reported in the literature (Table 2.3). The known metabolites for which ions were 
detected in the untargeted metabolomics analysis include aureusimines A and B, AIP-I, 
formylated and deformylated δ – toxin, phenol soluble modulin (PSM) α-2 and PSMα-3 
(see ions color coded and labeled in Figurer 2.1).  In addition to the expected known 
MRSA metabolites, a number of additional features were detected among the top 5% of 
ions with highest selectivity ratios (shown unlabeled in grey in Figure 2.1).  These 
features could be unidentified adducts, fragments, or charge states of known metabolites 
or could correspond to hitherto unidentified MRSA metabolites.  Future studies to assign 
structures to the unidentified features would be of interest. The data in Figure 2.1 
illustrate the utility of selectivity ratio analysis as a methodology for interpreting 
untargeted metabolomics data; it is far simpler to find 49 relevant features from among 
87 features, than from the total of 2090 features.  Additionally, the number of potential 




Figure. 2.1.  Histogram showing selectivity ratio (SR) for each feature in the untargeted metabolomics dataset for the 
24-hour growth experiment shown in Figure 2.2. The MRSA was sampled every two hr and the metabolite profiles for each 
time point collected using UPLC-MS. OD600 measurements (indicating bacterial growth) at each timepoint were used as the 
dependent variable in calculating the selectivity ratio. The x-axis represents the feature (identified by its m/z) detected in the 
metabolomics dataset.  Features are shown in order of increasing m/z. Peaks are numbered to correspond with known 
metabolites that were detected as shown in Table 2.3. Higher selectivity ratio indicates stronger correlation with growth (as 
measured by OD600). 87 features had selectivity ratios above 0.36, 49 of which were putatively identified as ions associated 












Table 2.3. Known secondary metabolites produced by MRSA indicating structure 
and function.  All compounds were tentatively identified in the MRSA cultures based on  
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Confirmation of detection of known MRSA metabolites 
The structural assignments indicated in Figure 2.1 are only tentative, relying on 
accurate mass measurement alone (Table 2.4).  To provide a more rigorous confirmation 
of structure, correct identification of several of the known MRSA metabolites labeled in 
Figure 2.1 was confirmed by comparing accurate mass (Table 2.4), retention time 
(Figure 2.1), and MS-MS fragmentation data (Figure 2.2, 2.3 and 2.4) to that of 
available standards and previous literature.  Additional confirmation was provided by 
comparison with an agr deletion mutant and a ∆ausA deletion mutant (Figure 2.5). The 
ausA gene encodes a nonribosomal peptide synthetase that is essential for the 
biosynthesis of aureusimines [37, 38] hence the ∆ausA deletion mutant is deficient in 
aureusimine production.  The data for the mutants display the expected findings, AIP-I 
and δ-toxin are not produced in the agr mutant, and aureusimine B is not produced in the 
ΔausA deletion mutant.  The findings summarized in Figure 2.6 provide confirmation of 
correct structural assignment for the subset of metabolites indicated in Table 2.3 for 
which relevant standards and mutants were available. 
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 229.1332 229.1335 1.3093 
6 PSM α-2 [M + 3H]
3+
 769.4640 769.4604 -4.6786 
7 PSM α-3 [M + 3H]
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Figure 2.2.  MS/MS data of know MRSA metabolites. (A) AIP-I standard and (B) 
AIP-I bacterial culture. A precursor ion m/z of 961.3798 was employed to generate the 








Figure 2.3.  MS/MS data of know MRSA metabolites. (A) aureusimine B standard and 
(B) aureusimine B in bacterial culture. A precursor ion m/z of 229.1332 was employed to 








Figure 2.4.  MS/MS data of know MRSA metabolites. (A) formylated δ-toxin standard 
and (B) formylated δ-toxin in bacterial culture. A precursor ion m/z of 229.1332 was 








Figure 2.5. Comparison of selected ion chromatograms from targeted UPLC-MS 
analysis of MRSA metabolites (numbered as in Table 2.3). Data are shown for a 
clinical isolate of MRSA (LAC USA 300 strain AH1263), a ΔausA non-ribosomal 
peptide synthetase (NRPS) deletion mutant (AH2137), and an agr gene deletion mutant 
(AH1292).  The data in (A) compare retention time and mass for an AIP-I standard (m/z 
961.3798, [M+H]+) with the putative AIP-I ion in the MRSA cultures.  The data shown in 




strains of MRSA and demonstrate agreement in retention time and mass with the 
standard.  Panel (C) shows a comparison of aureusimine B production (m/z 229.1332 for 
[M+H]+) across all strains.  As expected, the same metabolites were detected for the 
aureusimine gene deletion mutant with the exception of aureusimines, which are absent.  
For the agr gene deletion mutant, metabolites regulated by the agr system (AIP and δ-
toxin) are not detected. 
 
 
Comparison of OD600 and mass spectrometric methods for monitoring bacterial growth  
The newly developed method for detecting MRSA metabolites was employed to 
track metabolite production over time (Figure 2.6).  Bacterial growth was monitored 
using the standard method of OD600 (optical density at 600 nm) measurements (Figure 
2.6A) while at the same time peak areas for metabolites of interest, AIP-I (Figure 2.6B), 
aureusimine B (Figure 2.6C) and formylated δ-toxin (Figure 2.6D) were also measured.  
Growth studies show that as the bacterial population increases (as measured by increase 
in OD600), abundance of individual known MRSA metabolites from different classes also 
increases (Figure 2.6). It is furthermore apparent that the time point at which each 
metabolite is first detected varies among the metabolites, AIP-I and aureusimine B were 
first detected at the four hr time point (Figure 2.6B and C), whereas formylated δ-toxin 
(Figure 2.6D) was not detected until 12 hr.  The differences in onset time for production 
of AIP-I and δ-toxin are expected based on gene regulation with the agr system in 
MRSA, which has been well described in the literature ([24]).  The promoter driving 
AIP-I biosynthesis functions at a low constitutive level, and the promoter driving δ-toxin 
expression strictly depends on AIP-I signal accumulation.   
It is also apparent from Figure 2.6 that metabolite production levels off in the 




production, although degradation of the metabolite would also cause an apparent leveling 
in production and cannot be ruled out.  Differences in the time at which signal levels off 
is observed between the various metabolites (Figure 2.6).  While AIP-I levels saturate 
quickly (after just 6 hr) (Figure 2.6B), aureusimine B (Figure 2.6C) production 
continues to increase up to 16 hr, even after saturation has been observed in OD600 
(Figure 2.6A).  The reason for the observed saturation in AIP response is biological 
(decreased production by bacteria or degradation of signal) not methodological (response 
in the mass spectrometer saturated at high concentrations).  A calibration curve of mass 
spectrometric peak area versus AIP concentration is linear up to a peak area of 1 × 108 
(Figure 2.7), while saturation in AIP signal is observed in Figure 2.6B at a response in 







Figure 2.6. Change in abundance of metabolites produced by a USA 300 clinical 
strain of MRSA over time. MRSA growth was measured by turbidity (OD600) (A).  In 
parallel, abundance of each metabolite was measured every two hr over a 24 hr time 
period using UPLC-MS. Signal for each metabolite was measured using the area under 
the curve of the selected ion chromatogram for the relevant ion, AIP-I (B), with m/z of 
[M+H]+ at 961.3798, aureusimine B (C) with m/z of [M+H]+ at 229.1332 m/z, formylated 








Figure 2.7. Calibration curve of auto-inducing peptide-I. Concentration range 1.0 × 
10-4 – 1.0 × 101 µg × mL-1 
 
 
 Targeted analyses of known metabolites in response to treatment with an antimicrobial 
or quorum quencher 
Building on the demonstrated ability of the newly developed method to 
simultaneously track the production of several metabolites associated with virulence of 
MRSA (AIP-I and formylated δ-toxin), we sought to demonstrate its applicability to track 
agr regulated quorum sensing inhibition.  Ambuic acid has previously been shown to act 
as an inhibitor of the agr system [36], while chloramphenicol is a well-known bacterial 
protein synthesis antibiotic [53].  Therefore, we monitored the influence of these 
compounds on metabolite production by MRSA across a range of concentrations.  
Consistent with its antimicrobial activity, chloramphenicol treatment inhibited the 
production of the three measured metabolites (Figurer 2.8 B, D, and F).  Also as 




fashion (Figure 2.8A).   Suppression of AIP-I production should also result in decreased 
production of other secondary metabolites that are outputs of the quorum sensing system, 
including δ-toxin.  This expected result is observed in Figure 2.8C.  Consistent with 
previous literature [36], the observed suppression of AIP-I and formylated δ-toxin by 
ambuic acid treatment was not due to growth inhibition or growth delay.  These 
experiments were conducted using a short incubation time (6 hr) established previously 
[36], which achieves rapid MRSA growth by shaking at a high RPM.  As demonstrated in 
the growth curves that accompany Figure 2.6 (Figure 2.9), stationary phase was reached 
in the 6 hr incubation period, and ambuic acid caused no decrease in OD600 up to 100µM 
(Figure 2.9).  
In tandem with the quorum sensing inhibition measurements, we sought to 
employ the mass spectrometric method to monitor growth inhibition.  Several ions were 
identified based on the untargeted metabolomics experiments that could serve as 
candidates for tracking growth.  These ions were detected at m/z values of 198.0868, 
229.1332, 245.1285, 815.4288 and 871.4870 in positive ion mode mass spectrometry.   
Among these, only aureusimine B (m/z 229.1332) and aureusimine A (m/z 245.1285) 
were identified as known constituents of MRSA.  While the other ions appear to be 
MRSA constituents, their identities are currently unconfirmed.  The MS signal for 
aureusimine A was much lower than that of aureusimine B, making it less desirable for 
tracking MRSA growth.  Therefore, we focused these studies on aureusimine B.  Under 
the conditions employed herein, it appeared that aureusimine B was not strongly 




The data in Fig 2.8E suggest that aureusimine B production could be used as a 
means to track MRSA growth, and that, at least under the conditions employed in this 
study, the production of this metabolite appears not to be altered in the presence of a 
quorum sensing inhibitor.  Thus, by tracking agr regulated metabolites and aureusimine B 
simultaneously with UPLC-MS, it is possible to measure quorum sensing inhibition and 







Figure 2.8. Logarithmic dose inhibitory response of known MRSA metabolites to 
treatment with the quorum sensing inhibitor ambuic acid (A,C, and E) or the 
antimicrobial chloramphenicol (B, D and F).  Masses of the individual ions are 
indicated in Table 2.3. All peak areas were calculated as the average of triplicate 
cultures.  Error bars represent the standard error of the mean.  All metabolites decrease in 
abundance when treated with the antimicrobial chloramphenicol, while only the agr 
regulated metabolites (AIP-I and formylated δ-toxin) respond to treatment with ambuic 
acid.  Data were all collected when the bacterial cultures had reached stationary phase 
after a 6 hr incubation period.  Accompanying growth curves are provided in Figure 2.9.  
IC5o values indicate the concentration at which the measured response (peak area) is 






Figure 2.9. MRSA growth curves. (A) Growth curves for MRSA USA300 LAC 
(AH1263) treated with chloramphenicol over time. Each colored line represents either a 
control (2% DMSO) or a specific concentration of chloramphenicol.  (B) Growth curves 





With this study, we demonstrate that UPLC-MS can be employed to 
simultaneously monitor production of multiple secondary metabolites produced by 




method to track both growth and agr regulated virulence.  We show that aureusimine B 
production is correlated with bacterial growth, and that by monitoring aureusimine B 
production in tandem with the production of agr-regulated metabolites, it is possible to 
distinguish the effect of agr quorum sensing inhibitors and compounds from those that 
simply inhibit bacterial growth. The method developed herein could be of benefit to 
researchers who seek to obtain a more nuanced representation of how metabolite 
production changes over time or in response to the addition of inhibitors than is provided 
by OD600 data alone.  Additionally, this approach could be expanded to have utility in 
situations where OD600 readings are not possible, for example in measurements of 
bacterial growth in situ on surfaces.   
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The history of bacterial infections and their threat to humanity can be categorized 
with some of the first noted pandemics [54]. The ability of bacteria to evolve and develop 
mechanisms of resistance has increased the morbidity and mortality resulting from 
bacterial infections. Opportunistic pathogens such as methicillin-resistant Staphylococcus 
aureus (MRSA) have become resistant to some of the most aggressive antibiotics known 
to date. One potential cause of this Gram-positive bacterial pathogen, amongst many 
other pathogens, developing resistance is through the overuse of antibiotics. It has been 
suggested that the overuse of antibiotics has accelerated the development of resistance. 
As a result, many of these infections rely on last resort treatments, which involves a 
cocktail of antibiotics, whose side-effects are comparative to chemotherapeutic cocktails.  
There is an increasing need to find new approaches to treating drug-resistant bacterial 
infections.  One strategy is the so called “anti-virulence” strategy, which focuses on 




Staphylococcus aureus is a result of its ability to produce high levels of toxins that cause 
inflammation and cell damage in its host [12]. Toxin production in Staphylococcus 
aureus is controlled by two component regulatory systems [24]. The accessory gene 
regulator (agr) system, also called the quorum sensing system, is one of the key two-
component regulatory systems in Staphylococcus aureus [23, 24]. The agr system is 
regulated via bacterial cell density.  Activation of the agr system occurs when an 
autoinducing peptide (AIP) secreted by the bacteria binds to the extracellular receptor 
AgrC, a membrane- bound histidine kinase. Once activated by the external stimulus, the 
sensory protein goes through autophosphorylation, whereby the phosphoryl group that 
was once attached to the highly conserved histidine residue on the AgrC is transferred to 
the conserved aspartate residue on the response regulator, AgrA [55]. AgrD is the AIP 
pro-peptide. It contains a cyclic thiolactone ring and an amphiphatic C-terminal tail 
which is cleaved upon activation of the quorum sensing system. The protein AgrB is 
responsible for processing the AgrD precursor, cyclizing it and secreting it from the 
bacterium.  
Previous work of others including our group [17, 56] has enabled the 
identification and quantification of the auto-inducing peptide that is regulated by and also 
regulates the quorum sensing system in MRSA [16, 17] .   Recently, we developed a 
mass-spectrometric method that enabled the simultaneous detection of multiple 
metabolites produced by MRSA [57].  Building off of this previous work, the goal of this 
project was to use identify features in mass spectrometry datasets associated with 




using untargeted metabolomics and biochemometrics [6, 46, 48] analysis.  A key element 
in conducting these experiments is the calculation of a multivariate statistical parameter 
called the “selectivity ratio” which is a quantitative measure of the extent to which any 
given feature in the metabolomics dataset correlates with the observed activity [46, 58-
62]. 
Materials and Methods 
Bacterial culture 
A previously described method was used to evaluate the influence of inhibitors on 
MRSA metabolite production, with a slight modification [26].  Briefly a modified 
quorum sensing inhibitory assay [40] was used to allow for successful evaluation of 
metabolites influenced by the agr regulatory system.  All bacteria strains used for this 
experiment were provided by Dr. Alexander R. Horswill. The clinically relevant strain of 
MRSA (LAC USA300) were cultured in a clear lid, medical grade, gamma sterilized 
polystyrene petri dish (Fisher Scientific) on approximately 10 mL of a mixture of solid 
trypticase soy broth (Sigma Aldrich) at 31 g × L-1 with microbiological grade agar (Fisher 
Scientific) at 15 g × L-1, in accordance with the ATCC guidelines. Plates were cultured in 
a Stuart microtiter Shaker Incubator (SI505). The bacteria were incubated at 37 ˚C and 
shaken at 250 rpm, overnight. The bacteria cultured petri dishes were visually inspected 
for consistent bacterial colonies before culturing. A single colony of each strain of 
bacteria was cultured in approximately 5 mL of TSB and incubated at  37 ˚C and shaken 
at 200 rpm in a New Brunswick Scientific shaker/incubator series I-26 for at least 18 to 




200 rpm at 37 ˚C for time period in between 2 hr and 4hr to allow a proper optical density 
reading using 600 nm wavelength (OD600) in the range of 0.08 and 0.1. A 96-well tissue 
culture treated flat bottom plate (Corning Incorporated) was inoculated with 245 µL of 
diluted bacteria (200 µL TSB with addition of 45 µL of inoculated bacteria) and 5 µL of 
inhibitor, antagonist, or  control in each well. The inhibitors included ambuic acid 
(Adipogen Life Sciences), a known signal-biosynthesis inhibitor of the agr regulatory 
system [40] and the potent antimicrobial chloramphenicol (Sigma Aldrich) [63-65].  
These inhibitors were prepared at assay concentrations of 0.00µM to 100 µM, 0.00 µM  
to 300 µM, and 0.000 µM to 10 µM, respectively. Concentrated stock solutions of each 
were prepared in 100% microbiological grade dimethyl sulfoxide (DMSO) (Fisher-
Scientific). Vehicle control consisted of 2% DMSO.  Assays were performed in triplicate 
for each treatment and control. The plates were incubated at 37 ˚C and shaken at 1000 
rpm in the previously mentioned Stuart shaker incubator. The OD600 was measured in 1 hr 
intervals using a Synergy H1 Plate Reader until the measurements reached 2.0 at which 
point, the experiment was considered complete. The total incubation time was 
approximately 4-6 hr. At completion of incubation, the culture broth containing bacteria 
was transferred to a clear, sterile 96-well, 0.22 µm hydrophilic plate with low protein 
binding durapore membrane (MultiScreen®) and filtered under vacuum. The spent media 







UPLC-MS analysis of N-acetyl-L-histidine 
We recently published a method for understanding agr regulatory metabolite 
production over time. That study yielded the optimized UPLC-MS analysis parameters 
used here [57]. This same method was employed for all metabolomics studies with the 
slight modification that the divert valve was turned off to enable detection of the early-
eluting metabolite N-acetyl-L-histidine.   
   To confirm the identity of the N-acetyl-L-histidine, a standard of this compound 
(Sigma-Aldrich) was purchased and prepared in methanol and analyzed in parallel with 
MRSA spent media using the same UPLC-MS conditions [57] at a concentration of 10 
µg x mL-1.  Retention time, fragmentation pattern, accurate mass, and isotope pattern 
were compared between the standard and that of the putative N-acetyl-L-histidine ion in 
the MRSA spent media.  
Results and Discussion  
As demonstrated with the studies described in Chapter 2,  treatment of MRSA 
with chloramphenicol strongly inhibited bacterial growth (Figure 2.9A), while ambuic 
acid treatment showed very little evidence growth inhibition (Figure 2.9B), but inhibited 
the production of MRSA metabolites known to be regulated by the agr system (Figure 
2.8).  Therefore, selectivity ratio analysis was employed to the untargeted metabolomics 
datasets for chloramphenicol (Figure 3.1) and ambuic acid-treated MRSA (Figure 3.2) 
to explore which metabolites correlated with growth, and of those that correlated with 






Figure 3.1. Selectivity ratio plot obtained for metabolomics analysis of MRSA 
(strain AH1263) treated with chloramphenicol with OD600 concentration as the 
dependent variable. The data was filtered to include 107 features, of which we were 
able to positively correlate 34 known and unknown metabolites with a SR > 1.0. Many of 
the detected features were isotopes, adducts, multiply charged ions, or in-source 
fragments of the know metabolites (Table 2.1, Figure 3.1). Several unknown metabolites 
were also determined to correlate with growth of MRSA based on the data shown in 
Figure 3.1, and these are shown in Table 3.1 along with their charge state, if applicable, 











Figure 3.2. Selectivity ratio plot obtained for metabolomics analysis of MRSA 
(strain AH1263) treated with ambuic acid with ambuic acid concentration as the 
dependent variable. A total of 887 features were obtained in the dataset, with 36 
features having a selectivity ratio of < -0.5. The numbers for known metabolites 
correspond to Table 2.1 and the numbers for unidentified analytes correspond to Table 
3.1, and these are shown in Table 3.1 along with their charge state, if applicable. 
 
 
Table 3.1. Features chosen based on selectivity ratio analysis of the data obtained by 














1 961.37789|3.26 +1 Yes AIP-I 
(C43H61N9O12S2) 
2 745.4135|9.01 +4 Yes δ-toxin 
(C136H225N33O39S1) 
3 752.4135|9.03 +4 Yes formlyated δ-toxin 
(C137H225N33O41S1) 
4 245.1275|3.24 +1 No Aureusimine A 
(C14H16N2O3) 
5 229.1332|3.13 +1 No Aureusimine B 
(C14N16N2O) 





7 586.4134|9.32 +3 Yes PSMα-3 
(C110H190N26O30S1) 
8 189.1261|1.67  No -- 
9 198.0868|1.53 +1 No N-acteyl-L-histidine 
(C8H11N3O3) 
10 208.0964|1.43  No -- 
11 247.1436|2.21 +5 Yes  
12 259.1032|1.69  No -- 
13 360.1909|1.74  No -- 
14 429.3060|1.32  No -- 
15 451.7333|1.33  No -- 
16 519.2691|1.66 +2 Yes  
17 542.3894|2.48  No -- 
18 562.8196|4.40  No -- 
19 575.9659|2.98 +2 Yes In progress 
20 581.6607|3.44 +3 No -- 
21 588.6536|3.44 +3 No -- 
22 594.3098|3.45 +3 No -- 
23 621.3336|2.02 +1 No -- 
24 797.6908|7.46 +4 No -- 
25 798.1927|6.19 +4 No -- 
26 804.6061|2.86 +4 No -- 
27 815.4288|2.11 +1(?) No -- 
28 828.4717|3.21 +2 No -- 
29 863.4461|2.98 +2 Yes -- 
30 871.4870|3.44 +2 No -- 
31 882.4778|3.44 +2 No -- 
32 893.4688|3.44 +2 No -- 
33 957.5439|3.14 +2 Yes Peptide 
In progress 




Of the unknown metabolites shown in Table 3.1, we were particularly interested 
in those that regulated by the quorum sensing system. To identify which metabolites were 
agr quorum sensing system regulated, a similar selectivity ratio plot was constructed of 




concentration was used as the dependent variable.  Features with strongly negative 
selectivity ratio values were the features of interest, as these were the features that 
decreased in abundance with increasing concentration of ambuic acid added to the MRSA 
cultures.  Upon filtering, 34 features were identified with selectivity ratios below the 
empirically determined cut-off of -0.50 and labeled as “agr regulated” in Table 3.1. To 
confirm the trends predicted by the selectivity ratio analysis (Figures 3.1 and 3.2), we 
plotted dose-response curves for all of the ions listed in Table 3.1.  For these curves, we 
plotted abundance (peak area of the relevant selected ion trace) versus concentration of 
either ambuic acid or chloramphenicol in the culture medium.  Our prediction was that 
metabolites regulated by the agr system would display a decrease in peak area in 
response to both treatment with ambuic acid and treatment with chloramphenicol.  An 
example of this is shown for two agr-regulated metabolites in Figure 3.3 A-D, at m/z 
958.0460 and 863.4461.  Metabolites associated with MRSA growth but not regulated by 
the agr system would show a decrease in peak area only in response to treatment with 
chloramphenicol.  An example of this is shown for the metabolite detected at m/z 
198.0868 (Figure 3.3 E, F), which was ultimately identified as N-acetyl-L-histidine, as 


































IC50 = 18.74   1.45 M



















D: m/z 863.4461 response to ambuic acid








IC50 = 17.32   1.31 M



















F: m/z 198.0868 response to ambuic acid







IC50 > 100 M
 
 
Figure 3.3. Dose-response curves of unknowns. N-acetyl-L-histidine was is represented 
by (E and F). This supports our prediction that N-acteyl-L-histidine is not controlled by 





Identification of Unknowns 
As shown in Table 3.1, we assigned charge state of each of the unknown features based 
on spacing between isotopes.  Due to the low abundance of these unknowns, we were 
unable to obtain a molecular formula for the high mass metabolites shown in Table 3.1. 
However, molecular formula could be predicted for accurate mass of one of the growth-
associated metabolites, which was detected as a singly charged ion at m/z 198.0868.  
Based on published literature [66], we hypothesized that the identity of this metabolite 
was N-acetyl-L-histidine, a known metabolite of Staphylococcus aureus with molecular 
formula of C8H11N3O3. An authentic standard for N-acetyl-L-histidine was obtained, and 
the identity of the unknown metabolite was confirmed by comparing retention time, 






Figure 3.4. Selected ion chromatograms for m/z 198.0868 (calculated monoisotopic 
mass for [M+H]+ N-acetyl-L-histidine with 5 ppm mass tolerance). (A) represents 
analysis of an N-acetyl-L-histidine standard at a concentration of 10 µg/mL while B 






Figure 3.5.  MS-MS data obtained by collision induced dissociation (CID) of the 
precursor ion at m/z 198.0868 (calculated monoisotopic mass for [M+H]+ N-acetyl-
L-histidine). A 5 ppm mass tolerance for (A) N-acetyl-L-histidine standard at a 
concentration of 10 µg/mL and (B) analysis of the culture broth of MRSA (AH1263).   
 
 
Conclusion and Future Directions 
With these studies, we confirmed the presence of multiple unknown metabolites in 
MRSA cultures.  Several of the unknown metabolites were associated with MRSA 
growth but not agr regulated, and the identity of these was confirmed to be N-acetyl-L-




could be used to monitor MRSA growth, as described in Chapter 2 for our studies with 
aureusimines. 
The metabolites regulated by the agr system are of particular interest, as they might 
constitute new virulence factors of MRSA.  It is also possible, however, that these 
metabolites could be degraded products of other known agr outputs.  The identities and 
biological function of the agr regulated metabolites are the subject of ongoing 
experiments.  For these studies, we are scaling up MRSA cultures with the goal of 
isolating material for NMR analysis or producing sufficient MS signal to enable 

















IDENTIFICATION AND QUANTIFICATION OF ANTIMICROBIAL  
 





This chapter is under preparation for submission to Planta Medica.  Chantal V. Pelzer, 
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Botanicals are a major source of medicinally relevant compounds used to combat 
a multitude of diseases. Plant-based medicines are a major form of healthcare for an 
estimated 80% of the world’s population [68]. Existing literature has reported the 
biological significance and activity [6] of many chemical constituents present in 
botanicals. These include alkaloids [1], saponins [69], terpenoids [70], and polyphenols 
[4]), to name a few. As a result of the differing biological activity but similar chemical 




presented distinct analytical challengesRumex crispus is a member of the Polygonaceae 
family originally native to Europe and Asia but now seen in many countries [71]. It is a 
common weed of agriculture found especially in grassy areas, waste ground, roadsides, 
and near sand dunes [71]. The genus contains roughly 200 species [71]. Rumex crispus 
has extensive history in being used as an herbal remedy for its cleansing properties, and 
its holistic effect with people suffering from chronic skin problems in traditional   
medicine in many cultures [72]. The root of this plant has been traditionally by being 
mashed up or as a dried powder to treat sores, ulcers, wounds, and various other skin 
disorders [73]. 
Rumex crispus is rich in a chemical class of compounds known as anthraquinones, 
which  are reported to possess antimicrobial activity [74]. Of the anthraquinones from R. 
crispus, emodin is one of the most widely studied, and it is found in the root and bark of 
this and other plants, including various Chinese herbs. The compound is often physically 
described as an orange needle or powder derived from alcohol or by sublimation [71]. 
Herein, we sought to determine where emodin is responsible for the purported 
effectiveness of R. crispus as an antimicrobial against methicillin resistant 
Staphylococcus aureus.   We predicted based on the complexity of R. crispus root 
extracts that other constituents might also contribute to the activity of this botanical 
Materials and Methods 
General experimental procedures 
UPLC-MS analysis was completed in negative mode using a Q-Exactive Plus 




(Waters Corporation). When collecting UPLC-MS data, 3 μL of 1 mg × mL-1 samples 
suspended in MeOH were injected into the column. Using a flow rate of 0.3 mL × min-1, 
samples eluted from the column (BEH C18 1.7 μm, 2.1 × 50 mm, Waters Corporation) 
using the following gradient with solvent A consisting of water with 0.1% formic acid 
and solvent B consisting of acetonitrile with 0.1% formic acid: 90:10 (A:B) from 0-0.5 
min, increasing to 0:100 (A:B) from 0.5-8.0 min. The gradient was isocratically held at 
100% B for 0.5 min, before returning to starting conditions over 0.5 min and held from 
9.0-10.0 min. Mass analysis was completed in both positive and negative ionization 
modes over a scan range of 150-1500 with the following settings: capillary voltage at -
21.00 V, capillary temperature at 256.25 °C, tube lens offset at -95.00 V, spray voltage at 
3.50 kV, sheath gas flow at 47.50, and auxiliary gas flow at 11.25.  
Flash chromatographic separations were completed using A CombiFlash RF 
system (Teledyne-Isco) was used for flash chromatographic separation and this 
separation was examined using a PDA detector and an evaporative light scattering 
detector (ELSD).  
Plant material 
Fresh roots of Rumex crispus were collected on June 20, 2019 from the University 
of North Carolina at Greensboro Garden in Greensboro, North Carolina (N 36.07°, W 
79.81°). A voucher specimen of Rumex crispus roots was deposited at the herbarium of 







Fresh Rumex crispus roots were dried in a single wall transite oven (Blue M 
Electric Company) at 37 °C for 24 hours. The resulting dry mass (64.00 g) was ground 
using a Wiley Mill Standard Model No. 3 (Arthur Thomas Company) and submerged in 
methanol (MeOH) (Fisher Scientific, ACS grade)  at 160 g × L-1 for 24 hours. The 
resulting MeOH was drained from plant material and dried in a round bottom flask 
(Fisher) using a rotovap (G3 Heidolph, Heidolph Instruments).  Plant material was 
resubmerged for 24 hours with the MeOH previously extracted from the rotaovap. This 
process was repeated twice more (4 total).  During the last extraction, the MeOH was 
drained as before without drying down. Doubly deionized water (H2O) was added to 
MeOH (9:1 MeOH:H2O) and then sonicated to dissolve sum of the three extractions of 
the plant material in the same round bottom flask. The mixture was transferred into a 
separatory funnel for partitioning. The MeOH/H2O mixture was partitioned with hexane 
(1:1 MeOH/H2O: Hexane). The hexane was measured using a graduated cylinder. 
Hexane was transferred to the round bottom flask, gently swirled and slowly poured into 
the separatory funnel (repeated 3 times to include as much of the organic compounds 
from the round bottom flask as possible). The aqueous MeOH layer was partitioned 
further with ACS grade ethyl acetate (EtOAc) (Fisherscientific) empirically (4:1 
EtOAc/MeOH/H2O). To remove hydrosoluble tannins, the EtOAc layer was washed with 
a 1%  sodium chloride (NaCl) solution.  The resulting EtOAc extract was dried under 





Chromatographic separation  
The first-stage separations of the EtOAc extract (2470 mg) were conducted using 
normal-stage flash chromatography on a 40 g silica gel column.[45] The ELSD was set to 
55 °𝐶 and pressure of 1.5 bar. The nitrogen gauge was set at 20 psi. A 40 mL ×  min-1 
flow rate was used and a total column volume (CV) of 89.2 over a hexane/CHCl3/MeOH 
gradient. The gradient consisted of ACS grade chloroform (CHCl3) (Fisher Scientific) as 
solvent A1, methanol as solvent B1, and hexane as solvent B2. ISCO runs a dual solvent 
system and changes solvent within the duration of the run. At the beginning of the run, 
B2 was held isocratically at 100% for 5 CVs. The gradient (A1:B2) began at 5 CVs as B2 
decreased to 0% for 22 CVs. B2 was switched to B1 for 5 CVs. The gradient (A1:B1) 
increased to 0:100 for 32 CVs and B1 was held at 100 % for the last 25.2 CVs.  
Antimicrobial assay 
To evaluate antimicrobial activity, broth dilution assays were conducted by 
assessing growth inhibition of a clinically relevant strain of methicillin-resistant S. aureus 
(MRSA USA300 LAC strain AH1263) using Clinical Laboratory Standards Institutes 
(CLSI) methods [75]. This strain was obtained from Dr. Alexander Horswill at the 
University of Colorado Anschutz Medical Campus. Cultures were grown from a single 
colony isolate of MRSA in Müeller-Hinton broth (MHB) and diluted to 1.0 ×105 CFU × 
mL -1 based on absorbance at 600 nm (OD600).  
Rumex crispus roots extract and fractions were screened in triplicate at final 
concentrations of 10 and 100 μg × mL -1. Samples were dissolved in microbiological 




broth (MHB) (Sigm-Aldrich) to prepare final concentrations in broth with less than 2% 
DMSO. The known antibiotic chloramphenicol (98% purity, Sigma-Aldrich) was used as 
a positive control at the same concentrations as tested extracts and fractions. The vehicle 
was 2% DMSO in MHB. Blank wells consisted of samples at concentrations of 10 and 
100 μg × mL-1 without bacteria to use as a comparison for bacterial growth. Bacteria 
wells were inoculated and incubated for 24 hours at 37 °C. OD600 was evaluated after 
incubation and used to calculate the percent growth inhibition for biochemometric 
analysis (explained in detail in the section describing untargeted metabolomics analysis).      
Minimal inhibitory concentrations (MICs) were calculated for emodin (analytical 
standard, ≥ 97% purity, Sigma-Aldrich) and chloramphenicol (positive control, 98% 
purity, Sigma-Aldrich). The MIC is representative of the concentration at which either 
the control or the pure standard has completely inhibited the growth of bacteria. The 
inhibitory concentration at which bacterial growth is inhibited by 50 %, known as the 
IC50 or the EC50 were also calculated in order to properly predict activity of emodin based 
on the concentration of emodin in each sample. These values were determined using 
graphpad prism software (version 8.4.3) and can be further visualized in Figure 4.3.   
Emodin and chloramphenicol were added to 96-well plates in triplicate at concentrations 
ranging from 0-200 µg × mL-1 in MHB. Broth containing 2% DMSO was used as the 
vehicle control. The concentration of DMSO was set at a fixed value of 2% for all wells. 
After a 24-hour incubation at 37 °C, OD600 values were measured. The MIC was defined 
as the concentration at where no statistically significant difference between the blank 




Quantification of emodin and prediction of antimicrobial activity 
A calibration curve of emodin was constructed to quantify the amount of emodin 
in the extract and the subfractions of the extract. Emodin standards were prepared at a 
range of 1.00 × 10-3 to 1.00 × 102 µg × mL-1 in optima grade methanol (Fisher-Scientific 
and analyzed by UPLC-HRMS as described below.  Emodin concentration was 
determined by linear regression analysis of this calibration curve (Equation 4.1) where Y 
is the log10 (peak area of the ion at m/z 269.0455 for emodin in extract and fractions), m 
(0.5723) is the slope of the calibration curve, X is the log10(concentration of emodin, µg 
× mL-1), and  b (8.3240) is the y-intercept of the calibration curve.  
 
𝑌 = 𝑚𝑋 + 𝑏 Equation 4.1 
 
 
The predicted antimicrobial activity of emodin (Equation 4.2) was calculated based on its 
concentration in each extract and fraction and the dose-response relationship for growth 
inhibition of Staphylococcus aureus (Figure 1B).  This approach is similar to that 
employed by Caesar et. al. to predict antimicrobial activity of botanical extracts [76]. 
Where Y  is the predicted biological response emodin will have at a given concentration, 
min is the bottom of the dose-response curve (-0.2205), max is the top of the curve 
(0.9280), IC50 is the value for the point midway between the max and min also referred to 
as the half-maximal inhibitory concentration. The hillslope is a numerical value that 
characterizes the steepness of the slope at the midpoint (-0.603). Finally, x is the 











 Equation 4.2 
 
 
Untargeted metabolomics analysis 
UPLC-HRMS data were collected in negative mode and analyzed, aligned, and 
filtered utilizing MZmine 2.21.2 (http://mzmine.sourceforge.net/) [45] Raw mass spectral 
data files from first-stage fractions were uploaded for peak picking into MZmine. 
Chromatograms were constructed for all m/z values lasting from 1 to 10 minutes. The 
peak detection parameters were set as follows: noise level (absolute value) at 1 × 106,  
signal to noise threshold at 5, coefficient to area threshold at 10, minimum peak duration 
at 0 to 3 minutes, retention time wavelet range at 0 to 0.05, retention time tolerance at 0.5 
min., and m/z intensity tolerance at 20%. Peaks were aligned if their masses were within 
5 ppm from one another. Peak list filtering and retention time alignment were completed 
to produce an aligned peak list. The resulting data matrix, consisting of m/z, retention 
time, and peak area, was exported as a csv file to Excel (Microsoft). Filtered chemical 
data was merged with MRSA inhibition data from samples at tested at 100 μg × mL-1 to 
form the final data set for ready to be imported into software that can carry out 
bioinformatic approaches [77].  
Selectivity ratios were calculated using Sirius version 10.0 statistical software 
(Pattern Recognition Systems) [77]. Before analysis, data were adjusted using a 
transformation to normalize noise [78]. An internally cross-validated PLS model was 




internal to the Sirius software utilized model predictions to produce selectivity ratios 
identifying putative antimicrobial constituents. 
Results and Discussion 
Dose-response analysis of emodin and chloramphenicol against MRSA  
Chloramphenicol and emodin served as controls in this study, and the minimum 
inhibitory concentration of these compounds was evaluated for the purpose of 
establishing a baseline for comparison with this study and with published data [79]. The 
concentration of the known antimicrobial ranged from 0 to 200 µg × mL-1 . The MIC for 
chloramphenicol was at 12.5 µg × mL-1 (Figure 4.1 A) and the MIC for purified emodin 
was 200 µg × mL-1 (Figure 4.1 B).  Due to limited solubility, 200 µg × mL-1 was the 
highest emodin concentration tested, but growth inhibition was >95% at this 






Figure 4.1. Antimicrobial activity of chloramphenicol. (A) with minimum inhibitory 
concentration 12.5 μg × mL -1 and emodin (B) with minimum inhibitory concentration 
greater than 200 μg × mL -1 against MRSA LAC USA300. Both chloramphenicol and 
emodin were tested at concentrations ranging from 0 to 200 μg × mL -1 in biological 
triplicates. Samples were incubated for 24 hours and MRSA growth was measured by 
turbidity (OD600). The standard deviation was calculated and is indicated by the error 
bars.  For the purpose of this study MIC was defined as the concentration at which 
bacterial growth was inhibited by ≥ 90 %.  
 
 
Antimicrobial activity of R. crispus extracts and fractions 
Antimicrobial activity of a series of fractions from a complex R. crispus extract 




Fraction 3 demonstrated the most potent antimicrobial activity against methicillin-
resistant Staphylococcus aureus (MRSA, strain USA300 LAC ) [41]. Fractions 4-8 also 





Figure 4.2. Antimicrobial activity of Rumex crispus roots fractions 1-10 and extract 
at concentrations 100 μg × mL -1 and 10 μg ×  mL -1 (expressed as mass of extract or 
fraction per assay well volume) with DMSO as vehicle. Fractions 3-7 are the most 
active against MRSA LAC USA300 with percent inhibition > 50%. Comparison of 
predicted and observed antimicrobial activity of R. crispus fractions 1-10 and starting 
material (SM) at an assay concentration of 100 μg × mL -1 based on the content of 




no significant difference in observed and predicted values, however; active fraction 4-7 
have a greater observed than predicted activity (B).  
 
 
To determine whether the observed antimicrobial activity of the R. crispus fractions 
could be attributed to the known antimicrobial constituent emodin, UPLC-MS was used to 
identify and quantify this compound in the fractions (Figure 4.2B, Figure 4.3).   
 






















Y = 0.5723X + 8.324
  
 
Figure 4.3. Calibration curve of emodin was used  to obtain the concentration of 
emodin in the Rumex crispus extract. The x- and y-axis were both transformed to 
express values in the Log10. The concentration range of emodin used to make the 
calibration curve was 1.00 × 10-3 to 1.00 × 102 µg × mL-1. 
 
 
In parallel, the correct identification of emodin was confirmed by comparing 
the following qualities between the putative emodin in the R. crispus extract and purified 
emodin in negative polarity mode [M-H]- (1) accurate mass of 269.0457 ion (2) retention 
time.  Excellent agreement was observed between the standard and the putative emodin in 






Figure 4.4.  Comparison of the chromatographic data (A, B) and mass spectral data 
(C, D) for a an emodin standard (A and C) and the putative emodin ion in the 
Rumex crispus extract (B, D).  Excellent agreement is observed in both retention time 
and accurate mass between the emodin standard and the ion that is assigned to emodin in 




Figure 4.2B shows calculated (predicted based on MIC and quantity of emodin in 
each fraction) and measured antimicrobial activity of the R. crispus extracts and fractions. 
The concentration of emodin in each fraction was calculated using linear regression based 
on the calibration curve shown in Figure 4.4 from Equation 4.1. The predicted activity 
shown in Figure 4.2B was calculated using Equation 4.2.  While fractions 1-3 showed 
close alignment between predicted and observed activity, fractions 4-7 displayed higher 
activity than that which was predicted based on the measured emodin content (Figure 
4.2B).  These results demonstrate that the activity of fractions 4-7 must be partially 
attributable to compounds other than emodin.   
Untargeted metabolomics to identify features associated with antimicrobial activity 
Supervised analysis of metabolomics data was carried out using orthogonal partial 
least squares discriminant analysis (OPLS-DA). The purpose of this analysis was to 
determine which features detected in the Rumex crispus extract were most strongly 
associated with antimicrobial activity against MRSA, and to propose possible features 
(beyond emodin) that might be responsible for the antimicrobial activity of R. crispus. 
Bacterial growth as measured by the OD600 was used to guide our analysis, serving as 
the dependent variable. The independent variables were the features, each one 







Figure 4.5.  Orthogonal partial least squares discriminant analysis (OPLS-DA) 
scores plot (A) and loadings plot (B) of R. crispus fractions 1-10 and extract (SM). 
tested for antimicrobial activity against Staphylococcus aureus at 100 μg × mL -1. MRSA 
growth inhibition was measured in triplicate using OD600, the fractions, extract and pure 




orbitrap mass spectrometer) in triplicate. An independent chemical analysis by LC-MS 
was conducted for each solution measured in the antimicrobial assay.  Datapoints shown 
in green also demonstrated selectivity ratio values (SR) greater than 0.1 and are 
highlighted in Figure 4.6. 
 
 
OPLS-DA was utilized to describe the variance between each sample (starting 
material and fractions) of Rumex crispus. The scores plot is a visual representation of 
how the fractions group according to their antimicrobial activity.  The loadings plot 
depicts the features (m/z-RT pair), with their position in the plot demonstrating to what 
extent they explain the difference among sample.  
A second way of displaying the correlation between biological activity and 
chemical composition is the selectivity ratio plot (Figure 4.6).  Selectivity ratio analysis 
is used for this project as a ranking to determine which features of the R. crispus extract 
are associated with its antimicrobial activity. The selectivity ratio is the ratio of the 
explained variance to the unexplained variance in the dataset [77, 78, 80]. Features that 
are correlated with bioactivity will have strong positive selectivity ratios. For the data 
shown in Figure 4.6, emodin at m/z 269.0457, RT 5.23 min was positively correlated the 
most with MRSA growth inhibition by Rumex crispus fractions. Although emodin 
displays the highest positive correlation with increased bacterial growth inhibition, one of 
advantages of using the selectivity ratio analysis is the ability to detect and predict the 
activity of features detected at low levels [77, 80].  This analysis allowed us to identify 
more metabolites from R. crispus that correlated to the inhibition of MRSA growth 
(Figure 4.6). A selectivity ratio cut off of 0.10 was employed, which yielded a total of 10 




539.0435 (ID 10), respectively.  The level confidence of the identity of the annotated 
compounds are based upon scoring system described in previous literature [81]. Table 
4.1 refers to these scores as the MSI level of confidence. The scores ranged between 1 
and 4. Feature-ID 5 and 10 had a MS-I level of confidence score of 1. For features to 
have this score a standard (emodin, in this case) was used to confirm retention time and 
accurate mass.  Features with a confidence level of 2 (Feature-ID 1 and 6) were annotated 
based on their level of similarity to mass spectral data from its identification of plants of 
the same species. Confidence level 3 features were annotated because these small 
molecules had previously been identified in plants of the same genus or family. 
Confidence level 4 are unknown features, for which it is possible to predict a molecular 
formula based on MS spectral data, isotope pattern score to the online databases, and the 
accurate monoisotopic mass matching that of the predicted molecular formula within a 
tolerance of ± 10. All annotations in Table 4.1 are putative; further experiments 
employing NMR and other spectroscopic techniques for structural elucidation would be 
needed to confirm identities of these species.   
 
Table 4.1. Features identified as having selectivity ratios (Figure 4.6) ≥ 0.10 are 
shown along with MSI  level of confidence [81] for assignment of structure. 
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Figure 4.6. Selectivity ratio plot of R. crispus roots fractions 1-10 and extract at 100 
μg × mL -1. This plot shows the multivariate statistical analysis of the untargeted 
metabolomics dataset shows the features the correlate with growth inhibition. Percent 
growth inhibition of bacterial growth of each fraction or extract were used as the 
dependent variable. The x-axis represents the feature (identified by m/z and retention 
time) detected. Features are shown in order of increasing mass. Peaks are numbered to 
correspond with known and unknown metabolites that were detected. Higher selectivity 




With this project, we (1) quantified the emodin in Rumex crispus, (2) 
determined the predicted the bioactivity of extract fractions based on the presence of 
emodin, (3) used untargeted approaches to identify additional features in the dataset 
associated with antimicrobial activity.  This project shows that it is possible to identify 
and quantify emodin using UPLC-HRMS. Our findings show that emodin is not the only 




informatics analysis revealed that the presence of the compound omega-hydroxyemodin 
is also correlated with the antimicrobial activity of the R. crispus extract and fractions.  
This study suggests that a complex profile of metabolites may collectively be responsible 
for the antimicrobial activity of Rumex crispus.  
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CONCLUDING REMARKS AND FUTURE DIRECTIONS  
 
 




We are excited to have developed a method that can simultaneously track growth 
and virulence in MRSA using mass spectrometry. The work described in Chapter II 
provides scientists in the drug discovery and natural products field the unique ability to 
do mechanistic studies of MRSA using one optimized method. However, it should be 
noted that other scientists should optimize the parameters and ensure that they are 
reproducible for the particular application of interest.  
Future Directions 
While we were able to make significant scientific progress, there is always more 
that can be done. Regarding the work described in Chapter III, we are still working to 
identify the 34 unknown MRSA features with major emphasis on those regulated by the 
quorum sensing system of Staphylococcus aureus. Our prediction is that these features 
could be unreported degraded peptides or small proteins that could be MRSA virulence 
factors. We are currently training undergraduate and graduate students to carry this 
project forward. With the work described in Chapter IV, we report that the antimicrobial 
activity of Rumex crispus can be attributed to multiple small molecules.  This finding 




that cannot always be tracked to sincle molecules.  The work described in Chapter IV will 
be submitted for publication in a peer-reviewed journal. This is one of the most exciting 
chapters because it involved mentoring of students from underrepresented groups.  
As a scientist, who has now given back to the community of scientists, I am 
honored that my work is out there for everyone to see, and I hope that this dissertation 
work gives future scientists hope and the will power to push through. Getting a Ph.D. is 
no easy task; it takes commitment to finish the job. Getting a science Ph.D. takes 
understanding that the first experiment will most likely fail, but we should always look 
for the lessons in failed experiments. There are still learning opportunities in every 
experiment. If I could give one piece of advice, do not let the science intimidate you; 
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